Sequelae of tuberculous pleural effusion;Secuelas del derrame pleural tuberculoso

Medicina Clinica

Volumn 124, Issue 13, 2005, Pages 494-496

  Porcel, José Manuel ^a   Rubio Caballero, Manuel ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; PREDNISOLONE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

BRONCHOPLEURAL FISTULA; EDITORIAL; EMPYEMA; HEMATOTHORAX; HUMAN; IMMUNOREACTIVITY; LUNG TUBERCULOSIS; LUNG TUMOR; PATHOPHYSIOLOGY; RESIDUAL VOLUME; THORACOCENTESIS; TUBERCULOUS PLEURISY;

EID: 18844366214     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13073569     Document Type: Editorial

References (32)

1. Situació epidemiològica i tendència de l'endèmia tuberculosa a Catalunya. Memòria any 2003. Disponible en: http://www.gencat.net/salut/depsan/units/sanitat/html/ca/tuberculosi/index. html
2. Porcel JM, Rubio-Caballero M. Evaluación diagnóstica del derrame pleural. Med Clin (Barc). 2004;123:426-32.
3. Valdés L, Álvarez D, San José E, Penela P, Valle JM, García-Pazos JM, et al. Tuberculous pleurisy. A study of 254 patients. Arch Intern Med. 1998;158:2017-21.
4. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest. 2003;124:978-83.
5. Cohen M, Sahn SA. Resolution of pleural effusions. Chest. 2001;119: 1547-62.
6. Al-Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med. 1996;90:211-4.
7. Choi YW, Jeon SC, Seo HS, Park CK, Park SS, Hahm CK, et al. Tuberculous pleural effusion: new pulmonary lesions during treatment. Radiology. 2002;224:493-502.
8. Barbas CS, Cukier A, de Varvalho CR, Barbas Filho JV, Light RW. The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. Chest. 1991;100: 1264-7.
9. Soler JJ, Gil-Suay V, Cordero P, Perpiñá M, Martínez E, Sanchis J. Engrosamiento pleural en el derrame pleural tuberculoso. Factures asociados. Arch Bronconeumol. 1995;31:157-61.
10. Haro M, Ruiz-Manzano J, Morera J, Manterola JM, Fiz JA, Izquierdo J. Factores asociados al engrosamiento pleural en la pleuritis tuberculosa. Análisis de 99 casos. An Med Intern (Madrid). 1996;13:364-8.
11. De Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest. 1997;112:1293-7.
12. Hua CC, Chang LC, Chen YC, Chang SC. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest. 1999;116:1292-6.
13. Ruiz E, Alegre J, Alemán C, Vizcaya S, Armadans L, Segura RM, et al. Engrosamiento pleural residual en la pleuritis tuberculosa. Factores asociados. Arch Bronconeumol. 2000;36:506-9.
14. Kunter E, Ilvan A, Kilic E, Cerrahoglu K, Isitmangil T, Capraz F, et al. The effect of pleural fluid content on the development of pleural thickness, Int J Tuberc Lung Dis. 2002;6:516-22.
15. Wong CF, Yew WW, Leung SK, Chan CY, Hui M, Au-Yeang C, et al. Assay of pleural fluid interleukin-6, tumour necrosis factor-alpha and interferon-gamma in the diagnosis and outcome correlation of tuberculous effusion. Respir Med. 2003;97:1289-95.
16. Lai YF, Chao TY, Wang YH, Lin AS. Pigtail drainage in the treatment of tuberculous pleural effusions: a randomised study. Thorax. 2003;58: 149-52.
17. Kwak SM, Park CS, Cho JH, Ryu JS, Kim SK, Chang J, et al. The effects of urokinase instillation therapy via percutaneous transthoracic catheter in loculated tuberculous pleural effusion: a randomized prospective study. Yonsei Med J. 2004;45:822-8.
18. Montera Ruiz E, López Álvarez J, Hernández Ahijado C, Rojas Giraldo R. Factores pronósticos de la evolución clínica del derrame pleural tuberculoso. Med Clin (Barc). 2005;124:491-3.
19. Alemán C, Alegre J, Monasterio J, Segura RM, Armadans L, Anglés A, et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond). 2003;105:601-7.
20. Porcel JM, Vives M, Gázquez I, Vicente de Vera MC, Pérez B, Rubio M. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions. Int J Tuberc Lung Dis. 2000;4: 76-82.
21. Candela A, Andujar J, Hernández L, Martín C, Barroso E, Arriero JM, et al. Functional sequelae of tuberculous pleurisy in patients correctly treated. Chest. 2003;123:1996-2000.
22. Freixinet JG, Rivas JJ, Rodriguez De Castro F, Caminero JA, Rodríguez P, Serra M, et al. Role of surgery in pulmonary tuberculosis. Med Sci Monit. 2002;8:782-6.
23. Hoheisel G, Vogtmann M, Chan KS, Luk WK, Chan CHS. Pleuritis tuberculosa - therapeutische Wertigkeit wiederholter Pleurapunktionen. Pneumologie. 2004;58:23-7.
24. Matchaba PT, Volmink J. Steroids for treating tuberculous pleurisy. Cochrane Database Syst Rev. 2000;2;CD001876.
25. Elliott AM, Luzze H, Quigley MA, Nakiyingi JS, Kyaligonza S, Namujju PB, et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis. 2004;190:869-78.
26. Porcel JM, Rodríguez-Panadero F. ¿Cuando y cómo drenar un derrame pleural? Med Clin (Barc). 2002;118:265-7.
27. Porcel JM, Madroñero AB, Bielsa S. Tuberculous empyema necessitatis. Respiration. 2004;71:191.
28. Al-Kattan KM. Management of tuberculous empyema. Eur J Cardiothorac Surg. 2000;17:251-4.
29. Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology. 2004;9:428-40.
30. Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, et al. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol. 1993;92:32-8.
31. Allen SS, Cassone L, Lasco TM, McMurray DN. Effect of neutralizing transforming growth factor betal on the immune response against Mycobacterium tuberculosis in guinea pigs. Infect Immun. 2004;72:1358-63.
32. Kunz CR, Jadus MR, Kukes GD, Kramer F, Nguyen VN, Sasse SA. Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema. Chest. 2004;126:1636-44.